Skip to main content

Table 4 Factors associated with referral to EGD (multivariable generalized linear mixed effects models, GLMM). Statistically significant results are highlighted in bold font

From: Performance of the UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract 2.0 instrument as a clinical decision aid in the routine clinical care of patients with systemic sclerosis

Multivariable GLMM

Parameters

Models*

OR

95% CI

p

AUC (95% CI)

Age

Model 1

0.99

0.97–1.01

0.269

0.75 (0.69–0.80)

Sex

 

0.66

0.33–1.33

0.242

 

Disease duration

 

1.00

0.98–1.02

0.926

 

SSc subset

 

1.27

0.67–2.40

0.471

 

mRSS

 

1.05

1.00–1.10

0.030

 

Hb

 

0.89

0.74–1.07

0.218

 

PPI

 

0.80

0.49–1.30

0.363

 

BMI

 

1.03

0.97–1.09

0.294

 

FVC

 

1.00

0.99–1.01

0.948

 

ESR

 

1.00

0.99–1.02

0.943

 

Barrett’s esophagus

 

24.4

2.43–245.18

0.007

 

Heartburn

Model 2

2.23

1.35–3.69

0.002

0.71 (0.65–0.76)

Regurgitation

 

2.09

1.14–3.81

0.017

 

Dysphagia

 

3.01

1.79–5.05

< 0.001

 

Vomiting

 

1.98

0.62–6.25

0.247

 

Esophageal symptoms

Model 3

1.91

1.14–3.18

0.013

0.68 (0.62–0.74)

Stomach symptoms

 

2.12

1.24–3.61

0.006

 

Reflux subscale

Model 4

1.86

1.19–2.90

0.006

0.68 (0.62–0.74)

Distention/bloating subscale

Model 5

1.50

1.12–2.01

0.007

0.70 (0.65–0.76)

Social functioning

Model 6

2.57

1.56–4.23

< 0.001

0.65 (0.59–0.71)

Emotional wellbeing

Model 7

1.32

0.80–2.19

0.274

0.68 (0.62–0.74)

Total UCLA GIT 2.0 score

Model 8

2.16

1.21–3.83

0.009

0.64 (0.58–0.70)

  1. *Model 1 contains the covariates age, sex, disease duration, PPI therapy, mRSS, ESR, Hb, FVC, Barrett’s esophagus, BMI, and a subset of SSc. All other models contain, in addition to the covariates of model 1, the following covariates: model 2: heartburn, regurgitation, dysphagia, and vomiting; model 3: the symptom clusters “esophageal symptoms” and “stomach symptoms” as per expert opinion; and models 4–8: one of the mentioned subscales of UCLA GIT 2.0, respectively the total UCLA GIT 2.0 score
  2. mRSS modified Rodnan skin score, Hb hemoglobin, ESR erythrocyte sedimentation rate, PPI proton pump inhibitors, FVC forced vital capacity, BMI body mass index